NOVARTIS

📅 Upcoming

🕒 Recent(90d)

News

• Platinum-based chemotherapy in childhood causes mutations that age the liver
  Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly raising the long-term risk of new tumors
  stat · 7h ago
• Why two promising heart drugs flopped and what’s next
  This week on "The Readout LOUD" podcast: Two experimental drugs were heralded as the next era in heart disease treatment — why did they fail?
  stat · 8h ago
• STAT+: The gifts from pharma companies that keep on giving
  There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean doctors have reconsidered.
  stat · 9h ago
• STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
  A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks
  stat · 12h ago
• STAT+: Cancer medicines remain in short supply across the U.S., survey finds
  An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around strategies to treat patients and a majority also report that clinical trials…
  stat · 12h ago
• Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
  Novartis’ recent dual clinical setbacks have prompted questions from a major shareholder about the board’s oversight of dealmaking.
  fiercebiotech · 15h ago
• August biopharma layoffs impact just over 500, down 90% year over year
  Last month, biotech and pharma companies making or planning workforce cuts included three whose reductions will more than halve their workforces. Blueprint Medicines’ layoffs will affect the most e…
  biospace · 18h ago
• Merck adds 53 to New Jersey chopping block
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 1d ago
• STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
  An AstraZeneca drug reduced the dangerous flare-ups that worsen COPD in a pair of late-stage trials
  stat · 1d ago
• Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
  The company is investing billions of dollars to construct a European biosimilar hub capable of supporting the rapid expansion of its portfolio.
  biospace · 1d ago